doi: 10.1016/j.cmi.2017.02.012.
Epub 2017 Feb 22.
Prevalence, patient characteristics and outcomes of a novel piperacillin/tazobactam-resistant, pan-β-lactam-susceptible phenotype in Enterobacteriaceae: implications for selective reporting
Affiliations
- PMID: 28254605
- DOI: 10.1016/j.cmi.2017.02.012
Item in Clipboard
Prevalence, patient characteristics and outcomes of a novel piperacillin/tazobactam-resistant, pan-β-lactam-susceptible phenotype in Enterobacteriaceae: implications for selective reporting
Clin Microbiol Infect.
2017 Aug.
Free article
No abstract available
Similar articles
-
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.Antimicrob Agents Chemother. 2015 Oct 19;60(1):245-51. doi: 10.1128/AAC.00956-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26482308 Free PMC article.
-
Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam.Clin Microbiol Infect. 2008 Jan;14 Suppl 1:181-4. doi: 10.1111/j.1469-0691.2007.01864.x. Clin Microbiol Infect. 2008. PMID: 18154544 Review.
-
In Vitro-In Vivo Discordance with Humanized Piperacillin-Tazobactam Exposures against Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Klebsiella pneumoniae Strains.Antimicrob Agents Chemother. 2017 Jun 27;61(7):e00491-17. doi: 10.1128/AAC.00491-17. Print 2017 Jul. Antimicrob Agents Chemother. 2017. PMID: 28607019 Free PMC article.
-
Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid.Chemotherapy. 2007;53(3):185-9. doi: 10.1159/000100516. Epub 2007 Mar 7. Chemotherapy. 2007. PMID: 17347564
-
Clinical significance of extended-spectrum beta-lactamases.Expert Rev Anti Infect Ther. 2008 Oct;6(5):671-83. doi: 10.1586/14787210.6.5.671. Expert Rev Anti Infect Ther. 2008. PMID: 18847405 Review.
Cited by
-
Treatment of Piperacillin-Tazobactam-Nonsusceptible/Ceftriaxone-Susceptible Infections With Carbapenem Versus Carbapenem-Sparing Antimicrobials.Open Forum Infect Dis. 2023 Jun 8;10(6):ofad262. doi: 10.1093/ofid/ofad262. eCollection 2023 Jun. Open Forum Infect Dis. 2023. PMID: 37305841 Free PMC article.
-
Piperacillin/tazobactam resistance in a clinical isolate of Escherichia coli due to IS26-mediated amplification of blaTEM-1B.Nat Commun. 2020 Oct 1;11(1):4915. doi: 10.1038/s41467-020-18668-2. Nat Commun. 2020. PMID: 33004811 Free PMC article.
-
Effects of cascade reporting of susceptibility profiles for Enterobacterales on broad-spectrum antibiotics use and resistance.Eur J Hosp Pharm. 2022 Mar;29(2):79-83. doi: 10.1136/ejhpharm-2021-002951. Eur J Hosp Pharm. 2022. PMID: 35190452 Free PMC article.
-
Epidemiology of Bloodstream Infections Caused by Escherichia coli and Klebsiella pneumoniae That Are Piperacillin-Tazobactam-Nonsusceptible but Ceftriaxone-Susceptible.Open Forum Infect Dis. 2018 Nov 19;5(12):ofy300. doi: 10.1093/ofid/ofy300. eCollection 2018 Dec. Open Forum Infect Dis. 2018. PMID: 30568979 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
